Company: IXHL
Filing Date: 2025-04-07
Form Type: 424B5
Source: 0001213900-25-029414
Chunk: 11

Company: Incannex Healthcare Inc.
Filing Date: 2025-04-07
Form: 424B5
Chunk 11
---
 pursuant to which the Company agreed to use reasonable best efforts to register the Securities for resale within thirty
(30) days of the filing date of the registration statement (or, in the event of a “limited review” or “full review”
seventy-five (75) days) and also agreed to call a special meeting of stockholders no later than sixty (60) days following the closing
of the Private Placement for the approval of (i) the issuance of the Series A Warrant Shares and adjustments to the exercise price and
shares in the Series A Warrants as required pursuant to the rules and regulations of the Nasdaq Stock Market LLC, and (ii) for an increase
in the authorized number of shares of Common Stock as may be required for the full exercise of the Series A Warrants. We are seeking stockholder
approval (“Stockholder Approval”) to (i) to approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance
of the Series A Warrant Shares and certain provisions of the Series A Warrants, (ii) approve a proposed amendment to our amended and restated
certificate of incorporation (the “Certificate of Incorporation”) to increase the total number of shares of common stock authorized
for issuance thereunder from 100,000,000 shares to 800,000,000 shares (the “Charter Amendment Proposal”), at a special meeting
of stockholders expected to be held on April 29, 2025.

On March 7, 2025, the Company
also entered into a placement agency agreement with R.F. Lafferty & Co., Inc. (“R.F. Lafferty”) as the sole placement
agent in connection with the Private Placement (the “Placement Agent”). As compensation to the Placement Agent, the Company
will pay a commission equal to 7.0% of the aggregate gross proceeds from the Private Placement.

The Private Placement closed
on March 10, 2025. The Securities issued in the Private Placement were issued and offered pursuant to the exemptions from registration
provided in Section 4(a)(2) under the Securities Act of 1933, as amended, and Rule 506(b) promulgated thereunder.

<div align='center'>S-3</div>

Implications of Being an Emerging Growth Company and a Smaller Reporting Company

We are an “emerging
growth company” as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS